During the last decade, surface plasmon resonance (SPR)-based optical biosensors are being used extensively for biomolecular interaction analysis, in addition, another emerging biosensing technology, quartz crystal microbalance (QCM) has also been introdu
During the last decade, surface plasmon resonance (SPR)-based optical biosensors are being used extensively for biomolecular interaction analysis, in addition, another emerging biosensing technology, quartz crystal microbalance (QCM) has also been introdu
若能在早期先导药物的研发进程中，预先以生物感测科技进行适切与深入的分析，不但可有效节省药物开发所需的时间与成本，更能有助于先导药物后续的最佳化。